ARTEROLANE MALEATE AND PIPERAQUINE PHOSPHATE: A NEW OPTION IN THE TREATMENT OF PLASMODIUM FALCIPARUM MALARIA
Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 3
Abstract
Malaria is holoendemic in India, claiming thousands of deaths annually. Recent data suggests that the burden of malaria, the most significant parasitic disease in the world, is increasing. India’s expansive geography and diverse climate supports ideal environment for sustaining malarial parasites and their vectors. The National Drug Policy of India recommends artemisinin based combination treatment for the management of malaria. Although the use of Artemisinin has strengthened global efforts to combat malaria, multi-drug resistance has increasingly become a major impediment to malaria control. The complete clearance of parasites is dependent on the partner drug in the combination being effective and also persisting at parasiticidal concentrations until most of the infecting parasites have been killed. Arterolane maleate (150mg) and piperaquine phosphate (750mg) combination is a novel antimalarial combination that is not based on artemisinin. This combination provides rapid clearance of parasitemia and malaria-related symptoms, coupled with prevention of recrudescence. Additionally, a short course treatment of 3 days encourages compliance. Combination of arterolane and piperaquine is a safe and well-tolerated drug combination, making it a welcome addition to the armamentarium against Plasmodium falciparum.
Authors and Affiliations
Suruchi Aditya*| Deptt. Of Pharmacology,Dr Harvansh Singh Judge Institute of Dental Sciences, Sector 25,Chandigarh, India-160 014, Ruchika Nandha| Deptt. Of Pharmacology,Dr Harvansh Singh Judge Institute of Dental Sciences, Sector 25,Chandigarh, India-160 014, Kavita Sekhri| President, Tyagi Pharmacy Association & Scientific Writer (Pharmacy), Chattarpur, New Delhi, India-110074, Prof. Satyanand Tyagi
Keywords
Related Articles
- EP ID EP1363
- DOI -
- Views 457
- Downloads 30
Possible Study of Drug-Drug Interactions between Lisinopril and Gliclazide in Experimental Animals
The most often problem in type II diabetic patients coexists with hypertension, the incidence of hypertension among diabetic patients is high. In this case, use a combination of medicine unavoidable (Polypharmacy). In su...
CLINICAL ASPECTS OF AZOOSPERMIA: A REVIEW
Infertility is defined as the failure of a couple to become pregnant after one year of regular, unprotected, sexual intercourse. Infertility is not "just a female problem" as there is a male infertility component in appr...
Comparative evaluation of antihypertensive effects of Ramipril vs. Losartan in patients with uncomplicated stage-1 hypertension
Hypertension is responsible for high morbidity and mortality in cardiovascular diseases. As Ramipril and Losartan are important ones due to extensive use, fewer side effects, low cost & availability in market, study was...
COMPARISON OF ERYTHROPOIETIN AND DARBEPOETIN IN CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE HOSPITAL
Chronic kidney disease (CKD), is a progressive loss of kidney function over several months to years and cause complications like anaemia. Erythropoiesis stimulating agents (ESAs) such as erythropoietin and darbepoetin a...
DERMAL TRANSPORT OF MACRO-MOLECULE MEDICINES
These delivery techniques may be perfect; they do have numerous weaknesses when contrasted with infusions. For instance, oral administration requires proficient assimilation through the gastrointestinal (GI) tract. In th...